YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The market is up 1.2% over the last week, and in the past year, it has climbed an impressive 27%, with earnings expected to grow by 17% per annum. Though the term 'penny stock' might sound like a relic of past trading days, these smaller o…
The market remained flat over the last week, yet it is up 28% over the past year with earnings expected to grow by 16% per annum in the coming years. In this context, identifying stocks that combine solid financials with growth potential i…
Nautilus Biotechnology logo Key Points Management reaffirmed a commercialization timetable with the Voyager Platform targeted for pre-orders in late 2026, customer installations beginning in early 2027 and broad availability in H1 2027, wh…
(RTTNews) - Nautilus Biotechnology, Inc. (NAUT), a company developing a single-molecule proteome analysis platform, reported its financial results for the first quarter ended March 31, 2026, highlighting progress toward commercialization a…
* Nautilus Biotechnology press release [https://seekingalpha.com/pr/20490057-nautilus-biotechnology-reports-first-quarter-2026-financial-results] (NAUT [https://seekingalpha.com/symbol/NAUT]): Q1 GAAP EPS of -$0.12 beats by $0.02. * Cash,…
A few weeks ago, a research paper out of MIT (the college) crossed my desk that most investors would have ignored. It was about worms. Specifically, it was about a team that had successfully mapped the entire brain of a microscopic worm —…
NEW YORK CITY, NY / ACCESS Newswire / March 26, 2026 / Investor Summit Group is excited to share that the presentations from Q1 Virtual Conference are now available on-demand. If you missed the live event, now's your chance to catch up at…
Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying st…
Nautilus Biotechnology Inc. Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager PlatformVeteran sales leader with proven proteo…
Nautilus Biotechnology logo Key Points Voyager was publicly unveiled and the Iterative Mapping Early Access Program launched ahead of schedule to transition into active customer engagement, with Nautilus targeting pre-orders in late 2026 a…
BETA Technologies, Inc. (NYSE:BETA) is among the 11 Newly-Listed NYSE Stocks to Buy Now.Jefferies Upgrades BETA Technologies, Inc. (BETA) to Buy On February 11, 2026, Jefferies analyst Sheila Kahyaoglu upgraded BETA Technologies, Inc. (NYS…
As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. This optimistic start to the month highlights a market environment where investors are…
Major U.S. stock indexes have recently pulled back after setting fresh all-time highs, reflecting a complex economic landscape influenced by geopolitical events and fluctuating oil prices. In this climate, investors often seek opportunitie…
As December 2025 begins, U.S. stock indexes have slipped, with major tech and cryptocurrency-tied shares experiencing declines amid a broader risk-off sentiment in the market. Despite this cautious atmosphere, investors continue to explore…
Image source: The Motley Fool. Date Tuesday, Oct. 28, 2025, at 8:30 a.m. ET Call participants Chief Executive Officer — Sujal Patel Chief Marketing Officer — Kentaro Suzuki Chief Financial Officer — Anna Mowry Need a quote from a Motley Fo…
Image source: The Motley Fool. Date Tuesday, Oct. 28, 2025, at 8:30 a.m. ET Call participants Chief Executive Officer — Sujal PatelChief Marketing Officer — Kentaro SuzukiChief Financial Officer — Anna Mowry Need a quote from a Motley Fool…
As major U.S. stock indexes continue to set fresh records, investors are closely watching the Federal Reserve's latest moves and the potential impact on market trends. In this context, penny stocks—often representing smaller or newer compa…
(RTTNews) - Biotech stocks surged in after-hours trading on Wednesday, October 22, led by Ventyx Biosciences, which soared over 88% on positive Phase 2 data. A mix of earnings updates, clinical news, and investor interest lifted several na…
(RTTNews) - Biotech stocks are showing renewed momentum, with several small-cap names posting notable after-hours gains and attracting investor attention. From insider buying and strategic partnerships to clinical trial progress and bold f…
(RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor conference appearances. Companies like…
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30…
Over the last 7 days, the United States market has risen by 2.7%, and over the past year, it is up by 13%, with earnings expected to grow annually by 15% in the coming years. In light of these conditions, investors might find value in penn…
SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced Nautilus co-founder and C…
SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its rese…
SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the third quarter ended Septembe…
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter…
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following in…
SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following inv…
SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the second quarter ended…
SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarte…
SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following inve…
SEATTLE, May 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31,…
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the first quarte…
In this piece, we will take a look at the Jeff Bezos Stock Portfolio: 10 Companies and Startups. For more Jeff Bezos investments, head on over to Jeff Bezos Stock Portfolio: 5 Companies and Startups. If there's one thing that can be said f…
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B.…
SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the selection of three researc…